Invesco Ltd. Emergent Bio Solutions Inc. Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Invesco Ltd. holds 747,959 shares of EBS stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
747,959
Previous 1,539,907
51.43%
Holding current value
$5.36 Million
Previous $14.7 Million
75.31%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding EBS
# of Institutions
179Shares Held
38.1MCall Options Held
128KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$27.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$23 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$17.9 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$16.5 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$12.3 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $358M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...